November 07, 2006
Product News from the 11/07/06 News Brief
The FDA has approved the first generic version of Galderma’s MetroGel-Vaginal (metronidazole), a treatment for bacterial vaginosis. The generic version, Metronidazole Vaginal Gel, is manufactured by QLT of Fort Collins, CO. The company is eligible for 180 days of generic drug exclusivity. NovaDel Pharma said its NitroMist (nitroglycerin lingual aerosol) has been approved by the FDA for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. North American commercial rights for NitroMist have been licensed to Par Pharmaceutical.